Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sulthiame - Shionogi Apnimed Sleep Science

Next Previous
Drug Profile

Sulthiame - Shionogi Apnimed Sleep Science

Alternative Names: SASS-002; Sulthiame; Sultia; Sultiame

Latest Information Update: 11 Nov 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Desitin Pharmaceuticals GmbH
  • Class Antiepileptic drugs; Benzene derivatives; Sleep disorder therapies; Small molecules; Sulfonamides; Thiazines
  • Mechanism of Action Carbonic anhydrase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Sleep apnoea syndrome

Most Recent Events

  • 03 Nov 2025 Efficacy and adverse events data from the phase II FLOW trial in Sleep apnea syndrome released by Apnimed
  • 25 Apr 2025 Apnimed acquires Sulthiame from Desitin Arzneimittel GmbH
  • 07 Sep 2024 Efficacy and adverse events data from a phase II trial in Sleep apnea syndrome presented at the 34th Annual Congress of the European Respiratory Society (ERS-2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top